. Author manuscript; available in PMC: 2010 Jun 21.

Published in final edited form as: Nutr Metab Cardiovasc Dis. 2009 Apr 11;20(1):15–21. doi: 10.1016/j.numecd.2009.02.007

Table 4.

Hazard rates for all-cause mortality, cardiovascular events and death by glycosylated hemoglobin tertiles.

	Glycosylated hemoglobin (%)

	≤5.6	5.61–6.20	≥6.21
All-cause mortality (n = 416)^b
Unadjusted HR (95% CI)	1.00 (ref)	0.97 (0.76, 1.23)	1.09 (0.86, 1.38)
Adjusted HR (95% CI)^a	1.00 (ref)	0.97 (0.77, 1.24)	1.16 (0.91, 1.47)
CV mortality (n = 139)^c
Unadjusted HR (95% CI)	1.00(ref)	0.63 (0.40, 0.98)	1.22 (0.84, 1.78)
Adjusted HR (95% CI)^a	1.00(ref)	0.66 (0.42, 1.04)	1.31 (0.90, 1.93)
Myocardial infarction (n = 90)
Unadjusted HR (95% CI)	1.00 (ref)	1.28 (0.76, 2.15)	1.42 (0.85, 2.36)
Adjusted HR (95% CI)^a	1.00 (ref)	1.36 (0.81, 2.30)	1.55 (0.93, 2.61)
Congestive heart failure (n = 155)
Unadjusted HR (95% CI)	1.00 (ref)	1.17 (0.79, 1.72)	1.27 (0.87, 1.87)
Adjusted HR (95% CI)^a	1.00 (ref)	1.15 (0.78, 1.71)	1.29 (0.88 1.91)
Stroke (111)
Unadjusted HR (95% CI)	1.00 (ref)	0.87 (0.54, 1.38)	1.06 (0.68, 1.66)
Adjusted HR (95% CI)^a	1.00 (ref)	0.87 (0.54, 1.39)	1.08 (0.69, 1.70)

Adjusted for age, gender, race, smoking, body mass index, hypertension, chronic kidney disease and low-density lipoprotein cholesterol. Abbreviations: see Table 3.

p-value for quadratic trend: 0.69.

p-value for quadratic trend: 0.50.